Skip to main content
. Author manuscript; available in PMC: 2014 Jan 15.
Published in final edited form as: Cancer. 2012 Jul 6;119(2):429–437. doi: 10.1002/cncr.27688

Table 6.

Normative Data for Respondents with No Co-morbidities or Hypertension Only

NFKSI-19 FKSI-15 NFKSI-DRS-13 FKSI-DRS-9
Range 076 Range 060 Range 052 Range 036
No medical comorbidities or chronic conditions (n=448)
 Mean 65.6 51.3 45.2 32.6
 Standard Deviation 7.8 6.4 5.3 3.8
 Minimum Observed Score 35.0 28.0 20.0 14.0
 25th Percentile 61.0 48.0 43.0 31.0
 50th Percentile (Median) 67.5 53.0 46.0 34.0
 75th Percentile 71.0 56.0 49.0 35.0
 Maximum Observed Score 76.0 60.0 52.0 36.0

Hypertension only (n=140)
 Mean 66.0 51.5 45.3 32.5
 Standard Deviation 6.9 5.9 4.8 3.2
 Minimum Observed Score 44.0 34.0 28.0 21.0
 25th Percentile 63.0 49.0 43.0 31.0
 50th Percentile (Median) 66.5 52.0 46.0 33.0
 75th Percentile 71.0 56.0 49.0 35.0
 Maximum Observed Score 76.0 60.0 52.0 36.0

No medical comorbidities or chronic conditions or hypertension (n=588)
 Mean 65.7 51.4 45.2 32.6
 Standard Deviation 7.6 6.3 5.2 3.6
 Minimum Observed Score 35.0 28.0 20.0 14.0
 25th Percentile 62.0 48.0 43.0 31.0
 50th Percentile (Median) 67.0 52.0 46.0 34.0
 75th Percentile 71.0 56.0 49.0 35.0
 Maximum Observed Score 76.0 60.0 52.0 36.0
HHS Vulnerability Disclosure